Differential contributions of rOat1 (Slc22a6) and rOat3 (Slc22a8) to the in vivo renal uptake of uremic toxins in rats

被引:47
|
作者
Deguchi, T
Kouno, Y
Terasaki, T
Takadate, A
Otagiri, M [1 ]
机构
[1] Kumamoto Univ, Grad Sch Pharmaceut Sci, Dept Biopharmaceut, Kumamoto 8620973, Japan
[2] Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Mol Biopharm & Genet, Aoba Ku, Sendai, Miyagi 9808578, Japan
[3] Tohoku Univ, New Ind Creat Hatchery Ctr, Aoba Ku, Sendai, Miyagi 9808578, Japan
[4] Japan Sci & Technol Agcy, Solut Oriented Res Sci & Technol, Saitama 3320012, Japan
[5] Daiichi Coll Pharmaceut Sci, Minami Ku, Fukuoka 8150037, Japan
关键词
chronic renal failure; kidney uptake index; nephrotoxicity; organic anion transporters; uremic toxins;
D O I
10.1007/s11095-005-2486-x
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. Evidence suggests that uremic toxins such as hippurate ( HA), indoleacetate (IA), indoxyl sulfate ( IS), and 3-carboxy-4-methyl-5-propyl-2-furanpropionate ( CMPF) promote the progression of renal failure by damaging tubular cells via rat organic anion transporter 1 (rOat1) and rOat3 on the basolateral membrane of the proximal tubules. The purpose of the current study is to evaluate the in vivo transport mechanism responsible for their renal uptake. Methods. We investigated the uremic toxins transport mechanism using the abdominal aorta injection technique [i. e., kidney uptake index (KUI) method], assuming minimal mixing of the bolus with serum protein from circulating serum. Results. Maximum mixing was estimated to be 5.8% of rat serum by measuring estrone sulfate extraction after addition of 0 - 90% rat serum to the arterial injection solution. Saturable renal uptake of p-aminohippurate (PAH, K-m = 408 mu M) and benzylpenicillin (PCG, K-m = 346 mu M) was observed, respectively. The uptake of PAH and PCG was inhibited in a dose-dependent manner by unlabeled PCG (IC50 = 47.3 mM) and PAH (IC50 = 512 mu M), respectively, suggesting that different transporters are responsible for their uptake. A number of uremic toxins inhibited the renal uptake of PAH and PCG. Excess PAH, which could inhibit rOat1 and rOat3, completely inhibited the saturable uptake of IA, IS, and CMPF by the kidney, and by 85% for HA uptake. PCG inhibited the total saturable uptake of HA, IA, IS, and CMPF by 10%, 10%, 45%, and 65%, respectively, at the concentration selective for rOat3. Conclusions. rOat1 could be the primary mediator of the renal uptake of HA and IA, accounting for approximately 75% and 90% of their transport, respectively. rOat1 and rOat3 contributed equally to the renal uptake of IS. rOat3 could account for about 65% of the uptake of CMPF under in vivo physiologic conditions. These results suggest that rOat1 and rOat3 play an important role in the renal uptake of uremic toxins and the induction of their nephrotoxicity.
引用
收藏
页码:619 / 627
页数:9
相关论文
共 29 条
  • [1] Differential Contributions of rOat1 (Slc22a6) and rOat3 (Slc22a8) to the in Vivo Renal Uptake of Uremic Toxins in Rats
    Tsuneo Deguchi
    Yousuke Kouno
    Tetsuya Terasaki
    Akira Takadate
    Masaki Otagiri
    Pharmaceutical Research, 2005, 22 : 619 - 627
  • [2] Functional involvement of rat organic anion transporter 3 (rOat3; Slc22a8) in the renal uptake of organic anions
    Hasegawa, M
    Kusuhara, H
    Sugiyama, D
    Ito, K
    Ueda, S
    Endou, H
    Sugiyama, Y
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 300 (03): : 746 - 753
  • [3] Drug Clearance from Cerebrospinal Fluid Mediated by Organic Anion Transporters 1 (Slc22a6) and 3 (Slc22a8) at Arachnoid Membrane of Rats
    Zhang, Zhengyu
    Tachikawa, Masanori
    Uchida, Yasuo
    Terasaki, Tetsuya
    MOLECULAR PHARMACEUTICS, 2018, 15 (03) : 911 - 922
  • [4] Analyses of 5′ regulatory region polymorphisms in human SLC22A6 (OAT1) and SLC22A8 (OAT3)
    Vibha Bhatnagar
    Gang Xu
    Bruce A. Hamilton
    David M. Truong
    Satish A. Eraly
    Wei Wu
    Sanjay K. Nigam
    Journal of Human Genetics, 2006, 51 : 575 - 580
  • [5] Analyses of 5' regulatory region polymorphisms in human SLC22A6 (OAT1) and SLC22A8 (OAT3)
    Bhatnagar, Vibha
    Xu, Gang
    Hamilton, Bruce A.
    Truong, David M.
    Eraly, Satish A.
    Wu, Wei
    Nigam, Sanjay K.
    JOURNAL OF HUMAN GENETICS, 2006, 51 (06) : 575 - 580
  • [6] Sex-dependent expression of Oat3 (Slc22a8) and Oat1 (Slc22a6) proteins in murine kidneys
    Breljak, Davorka
    Brzica, Hrvoje
    Sweet, Douglas H.
    Anzai, Naohiko
    Sabolic, Ivan
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2013, 304 (08) : F1114 - F1126
  • [7] Interaction of five anthraquinones from rhubarb with human organic anion transporter 1 (SLC22A6) and 3 (SLC22A8) and drug-drug interaction in rats
    Ma, Liping
    Zhao, Lei
    Hu, Haihong
    Qin, Yahong
    Bian, Yicong
    Jiang, Huidi
    Zhou, Hui
    Yu, Lushan
    Zeng, Su
    JOURNAL OF ETHNOPHARMACOLOGY, 2014, 153 (03) : 864 - 871
  • [8] Activation of Protein Kinase Cζ Increases OAT1 (SLC22A6)- and OAT3 (SLC22A8)-mediated Transport
    Barros, Scott A.
    Srimaroeng, Chutima
    Perry, Jennifer L.
    Walden, Ramsey
    Dembla-Rajpal, Neetu
    Sweet, Douglas H.
    Pritchard, John B.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (05) : 2672 - 2679
  • [9] Interaction of Natural Dietary and Herbal Anionic Compounds and Flavonoids with Human Organic Anion Transporters 1 (SLC22A6), 3 (SLC22A8), and 4 (SLC22A11)
    Wang, Li
    Sweet, Douglas H.
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2013, 2013
  • [10] Potential for food-drug interactions by dietary phenolic acids on human organic anion transporters 1 (SLC22A6), 3 (SLC22A8), and 4 (SLC22A11)
    Wang, Li
    Sweet, Douglas H.
    BIOCHEMICAL PHARMACOLOGY, 2012, 84 (08) : 1088 - 1095